Come up with a name for your new list and we'll add to it:
Apath raised a round of funding on , . Investors include
Nidus Center for Scientific Enterprise.
Apath is a pharmaceutical discovery and development company with a focus on the hepatitis C virus ("HCV") and other human viral pathogens. Apath was founded by Charles M. Rice, Ph.D., currently Profes…